Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

175
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
175
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

350
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
350
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

201
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
201
Relative Risk01:12

Relative Risk

550
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
550
Actuarial Approach01:20

Actuarial Approach

157
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
157
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

308
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
308

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perspective: Machine Learning for Health Should Consider Social Drivers of Health.

Proceedings of machine learning research·2026
Same author

Access to care affects electronic health record reliability and AI-driven disease prediction.

Nature health·2026
Same author

A Microsimulation-Based Approach for Mitigating Societal Bias in Chronic Kidney Disease Data.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same author

Practice Pattern Changes After Adoption Of Diagnostic AI Tool Used In Conjunction With Cardiac Imaging.

Health affairs (Project Hope)·2026
Same author

A Novel Decision-Modeling Framework for Health Policy Analyses When Outcomes Are Influenced by Social and Disease Processes.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same author

Advancing healthcare AI governance through a comprehensive maturity model based on systematic review.

NPJ digital medicine·2026
Same journal

Clarifying the relationship between biomedical and health informatics and digital health: expert perspectives.

BMJ health & care informatics·2026
Same journal

Measuring performance trajectories in lung cancer surgery: a longitudinal study using the French national hospital database from 2020 to 2024.

BMJ health & care informatics·2026
Same journal

Mapping of mental health indicators in the WHO European region: a scoping review.

BMJ health & care informatics·2026
Same journal

Automated monitoring in clinical and operational workflows.

BMJ health & care informatics·2026
Same journal

Characterising 'Watch and Wait' prescribing patterns in paediatric otitis media using large language models and pharmacy dispense data.

BMJ health & care informatics·2026
Same journal

Alzheimer's disease risk prediction from clinical and social determinants of health: a machine learning cohort study in UK Biobank.

BMJ health & care informatics·2026
See all related articles

Related Experiment Video

Updated: Oct 19, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K

Identifying undercompensated groups defined by multiple attributes in risk adjustment.

Anna Zink1, Sherri Rose2

  • 1PhD Candidate in Health Policy, Harvard University, Cambridge, Massachusetts, USA azink@g.harvard.edu.

BMJ Health & Care Informatics
|September 18, 2021
PubMed
Summary
This summary is machine-generated.

New methods reveal undercompensated patient groups in health insurance plan payments, particularly those with multiple chronic conditions. This highlights potential insurer discrimination and informs policy for equitable healthcare coverage.

Keywords:
delivery of Health Carehealth care sectorhealth equity

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K

Related Experiment Videos

Last Updated: Oct 19, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K

Area of Science:

  • Health economics
  • Health services research
  • Data science in healthcare

Background:

  • Existing methods for evaluating health plan payment risk adjustment are often arbitrary and inconsistent.
  • Identifying undercompensated patient groups, especially those with multiple attributes, is crucial for equitable healthcare.
  • Current risk adjustment formulas may inadvertently create incentives for insurers to discriminate against certain patient populations.

Purpose of the Study:

  • To develop a systematic approach for identifying undercompensated groups in health plan payment risk adjustment.
  • To improve upon existing arbitrary and inconsistent evaluation methods.
  • To pinpoint groups defined by multiple attributes that are systematically undercompensated.

Main Methods:

  • Developed a 'group importance' measure within the random forests algorithm, extending the concept of variable importance.
  • Utilized 2016-2018 IBM MarketScan and 2015-2018 Medicare claims and enrollment data for analysis.
  • Evaluated two risk adjustment scenarios: the individual health insurance Marketplaces formula and the Medicare formula.

Main Results:

  • Identified previously unrecognized undercompensated groups with multiple chronic conditions in the Marketplaces risk adjustment.
  • Observed overcompensation for groups without chronic conditions in the Marketplaces.
  • Found that the magnitude of undercompensation for multi-attribute groups significantly exceeds that for single-attribute groups.
  • No consistent under- or overcompensation patterns were detected for complex groups in the Medicare risk adjustment formula.

Conclusions:

  • The novel method effectively identifies complex undercompensated groups in health plan payment risk adjustment.
  • Undercompensation in risk adjustment can incentivize insurer discrimination against vulnerable patient groups.
  • This research offers policymakers insights into potential discrimination targets and a pathway toward more equitable health coverage.